# 160 Health International

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/160-health-international

- Industry: Healthcare
- Headquarters: Grand Cayman, Cayman Islands
- Website: www.91160.com/
- Total disclosed funding: $86M
- Latest round: Series D (Dec 28, 2021)
- Investors on record: 7

## About

Based in the Cayman Island and founded in 2005 under the name Shenzhen Ningyuan Technology Co., Ltd., 160 Health International Limited operated as a healthcare provider, initially focusing on hospital and clinic services.  In 2022, the company was incorporated in the Cayman Islands as an exempted company with limited liability to serve as the offshore listing vehicle for its IPO preparation. Over time, the company expanded its service offerings into health management and related healthcare solutions. It has developed its footprint across China through affiliated healthcare institutions. The company continues to expand its medical service capacity, with a focus on improving operational efficiency and providing accessible healthcare. In September 2025, it listed on the Hong Kong Exchanges And Clearing Ltd(HKEX) under the ticker 2656.

The company operates hospitals and clinics, offering outpatient and inpatient medical services, preventive health management and other healthcare-related solutions.

160 Health International Limited generates revenue primarily from patient services, including consultation fees, diagnostic testing, inpatient and outpatient care, and preventive health management programs.

Following its IPO, the company plans to expand its healthcare network by establishing and acquiring additional hospitals and clinics, invest in digital healthcare technologies and enhance its health management service offerings to strengthen its market position and support long-term growth.

## Funding rounds

- Series D, Dec 28, 2021, $46M — Toposcend Capital
- Series D, Jan 8, 2021, $11M — Toposcend Capital, Litong Investment
- Series C, Mar 27, 2019, $5.7M — Jiangsu Yingchengxin Asset Management
- Series C, Mar 30, 2017, $1.7M — Yuanzhi Venture Capital
- Series C, Oct 20, 2016, $6.5M — ABC Capital, QF Capital
- Series B, Mar 19, 2015, $11M — CoStone Capital
- Series A, Jan 1, 2014, $3.6M — QF Capital
- Angel, Apr 18, 2012, $0.7M — QF Capital

## Investors

- QF Capital (https://capitalatlas.ai/funds/qf-capital) — Angel, Series A, Series C
- CoStone Capital (https://capitalatlas.ai/funds/costone-capital) — Series B
- ABC Capital (https://capitalatlas.ai/funds/abc-capital) — Series C
- Yuanzhi Venture Capital (https://capitalatlas.ai/funds/yuanzhi-venture-capital) — Series C
- Jiangsu Yingchengxin Asset Management (https://capitalatlas.ai/funds/jiangsu-yingchengxin-asset-management) — Series C
- Toposcend Capital (https://capitalatlas.ai/funds/toposcend-capital) — Series D
- Litong Investment — Series D